Zhejiang Langhua Pharmaceutical Co., Ltd.

Established in 1986, Zhejiang Langhua Pharmaceutical Co., Ltd is a comprehensive manufacturing enterprises focusing on API and intermediates production and CDMO projects. And it has been a main manufacturer for APIs and intermediates of quinolone, cardiovascular, anti-depressive and anti-HIV products. The present location is Zhejiang Provincial Chemical and Medical material base Linhai zone, covering area of 190000㎡ and employees of 500.
 

In addition to be considered as national High-Technology enterprises in China, Langhua has solid quality system. Since 2006, Langhua has passed the site audit and inspection from different authorities like CFDA, USFDA, WHO, EDQM and ANVISA. Meantime Langhua has been accepted by many prestigious multiple-national pharmaceutical companies, working as APIs supplier and CDMO partner. All the APIs products were listed on the GMP certificate.
 

Focusing on the International market, Langhua aims to become the most valuable and innovating API supplier and the clients’ preferred CDMO partner. Ensured by the quality management and risk control, based on the safe production, driven by the innovation, and supported by international registration, Langhua is taking more regulated market share and realizing the steady improvement of performance and competitiveness.

For over thirty years, Langhua employees have adhered to the enterprise culture and spirit of ”honesty, cooperation, learning and working meticulously, innovatively and excellently". Now with the philosophy of “Efficiency, Flexibility and Reliability”, Langhua strives to contribute to human health.